Revvity, Inc. (NYSE:RVTY) Stock Holdings Lessened by Whittier Trust Co. of Nevada Inc.

Whittier Trust Co. of Nevada Inc. reduced its holdings in Revvity, Inc. (NYSE:RVTY) by 33.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 1,333 shares of the company’s stock after selling 667 shares during the quarter. Whittier Trust Co. of Nevada Inc.’s holdings in Revvity were worth $149,000 as of its most recent filing with the SEC.

A number of other large investors also recently modified their holdings of RVTY. Empowered Funds LLC bought a new stake in Revvity in the 3rd quarter valued at about $227,000. Natixis Advisors LLC lifted its position in Revvity by 17.9% in the 3rd quarter. Natixis Advisors LLC now owns 12,499 shares of the company’s stock valued at $1,597,000 after purchasing an additional 1,901 shares during the last quarter. Quest Partners LLC bought a new stake in Revvity in the 3rd quarter valued at about $126,000. Pathstone Holdings LLC lifted its position in Revvity by 70.0% in the 3rd quarter. Pathstone Holdings LLC now owns 21,358 shares of the company’s stock valued at $2,728,000 after purchasing an additional 8,791 shares during the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Revvity in the 3rd quarter valued at about $393,000. 86.65% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

RVTY has been the topic of several research analyst reports. Barclays raised their target price on shares of Revvity from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Raymond James reissued an “outperform” rating and set a $145.00 target price (up previously from $140.00) on shares of Revvity in a research note on Monday, February 3rd. Sanford C. Bernstein cut shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 target price on the stock. in a research note on Friday, January 10th. Bank of America raised shares of Revvity from a “neutral” rating to a “buy” rating and set a $138.00 target price on the stock in a research note on Friday, December 13th. Finally, KeyCorp raised their target price on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a research note on Monday, February 3rd. Four equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $136.25.

Revvity Stock Performance

Shares of RVTY opened at $107.18 on Monday. The firm’s 50 day moving average is $116.44 and its 200-day moving average is $117.54. The stock has a market capitalization of $12.88 billion, a P/E ratio of 48.50, a P/E/G ratio of 3.82 and a beta of 1.06. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. Revvity, Inc. has a 12-month low of $97.32 and a 12-month high of $129.50.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Friday, January 31st. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.05. Revvity had a net margin of 9.81% and a return on equity of 7.68%. During the same period in the previous year, the company posted $1.25 EPS. Equities research analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Friday, April 18th will be issued a $0.07 dividend. This represents a $0.28 annualized dividend and a dividend yield of 0.26%. The ex-dividend date is Thursday, April 17th. Revvity’s payout ratio is 12.67%.

Insider Buying and Selling

In related news, insider Joel S. Goldberg sold 15,170 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $126.73, for a total transaction of $1,922,494.10. Following the transaction, the insider now owns 33,400 shares of the company’s stock, valued at approximately $4,232,782. The trade was a 31.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Tajinder S. Vohra sold 5,492 shares of the business’s stock in a transaction on Tuesday, January 7th. The stock was sold at an average price of $116.81, for a total transaction of $641,520.52. Following the transaction, the insider now directly owns 19,652 shares in the company, valued at $2,295,550.12. This trade represents a 21.84 % decrease in their position. The disclosure for this sale can be found here. 0.60% of the stock is currently owned by corporate insiders.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.